As part of our responsibilities for the Australian blood sector, we manage systems and data on behalf of all jurisdictions, collect data through our various ope
Xembify, a 20% concentration SCIg product supplied by Grifols Australia, will be available for supply under the national blood arrangements from January 2024.
